Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

AEE-788 inhibits human hepatocellular carcinoma in vitro and in vivo

April 13, 2007

ARRY-797 to be studied in cancer patients

April 12, 2007

Pancreatic cancer study of Erbitux plus gemcitabine misses endpoint

April 12, 2007

Reolysin studied in phase II trial for metastatic sarcomas

April 12, 2007

Dosing begins in phase I study of AC-220 for AML

April 12, 2007

FDA extends review period for Torisel NDA

April 12, 2007

Synergy seen with verotoxin-1 and monophosphoryl lipid A in mouse fibrosarcoma

April 12, 2007

Novel PARP-1 inhibitor described by Abbott

April 11, 2007

Phase II study of Curaxin CBLC-102 in prostate cancer advances to next stage

April 11, 2007

Phase II trial studies glufosfamide for soft tissue sarcoma

April 11, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...